MBAI Unveils Disruptive Pricing for Full MedMatrix Platform MedBright AI Investments Inc. (Ticker: MBAI.c or MBAIF for US investors) has unveiled the pricing for its MedMatrix AI Platform, marking a bold move in the healthcare technology sector. MedMatrix leverages AI to streamline outpatient clinical services, thus optimizing operations and boosting revenue.
MedMatrix's AI infrastructure analyzes patient needs, optimizes resources, manages revenue cycles, and devises market expansion strategies for healthcare facilities.
The launch of MedMatrix's full version and pricing coincides with the growth of the outpatient clinical services market, projected to reach US$1.37 trillion in revenue this year, with the US market exceeding US$729 billion.
With this, MBAI has introduced an innovative pricing model for MedMatrix, offering a commitment-free trial and no upfront costs. Its flexible pricing schedule adapts to clinic sizes and complexities, delivering tangible value to clients.
The revenue-sharing model aligns MedMatrix's success with client growth, earning 10% of additional revenue generated by its tools.
With a focus on disrupting healthcare technology, MedMatrix targets domestic as well as global markets.
More here
Posted on behalf of MedBright AI Investments Inc.